These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31986089)

  • 1. Broadly Neutralizing Antibodies for HIV Prevention.
    Karuna ST; Corey L
    Annu Rev Med; 2020 Jan; 71():329-346. PubMed ID: 31986089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadly Neutralizing Antibodies for HIV-1 Prevention.
    Walsh SR; Seaman MS
    Front Immunol; 2021; 12():712122. PubMed ID: 34354713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses.
    Berendam SJ; Styles TM; Morgan-Asiedu PK; Tenney D; Kumar A; Obregon-Perko V; Bar KJ; Saunders KO; Santra S; De Paris K; Tomaras GD; Chahroudi A; Permar SR; Amara RR; Fouda GG
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadly neutralizing monoclonal antibodies for HIV prevention.
    Miner MD; Corey L; Montefiori D
    J Int AIDS Soc; 2021 Nov; 24 Suppl 7(Suppl 7):e25829. PubMed ID: 34806308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.
    Mahomed S; Garrett N; Baxter C; Abdool Karim Q; Abdool Karim SS
    J Infect Dis; 2021 Feb; 223(3):370-380. PubMed ID: 32604408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention.
    Thavarajah JJ; Hønge BL; Wejse CM
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives.
    Mahomed S
    Clin Microbiol Rev; 2024 Jun; 37(2):e0015222. PubMed ID: 38687039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly neutralizing antibodies for HIV-1 prevention and therapy.
    Julg B; Barouch D
    Semin Immunol; 2021 Jan; 51():101475. PubMed ID: 33858765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly neutralizing antibodies for the treatment and prevention of HIV infection.
    Caskey M
    Curr Opin HIV AIDS; 2020 Jan; 15(1):49-55. PubMed ID: 31764199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.
    Stefic K; Bouvin-Pley M; Essat A; Visdeloup C; Moreau A; Goujard C; Chaix ML; Braibant M; Meyer L; Barin F
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial.
    Sobieszczyk ME; Mannheimer S; Paez CA; Yu C; Gamble T; Theodore DA; Chege W; Yacovone M; Hanscom B; Heptinstall J; Seaton KE; Zhang L; Miner MD; Eaton A; Weiner JA; Mayer K; Kalams S; Stephenson K; Julg B; Caskey M; Nussenzweig M; Gama L; Barouch DH; Ackerman ME; Tomaras GD; Huang Y; Montefiori D;
    Lancet HIV; 2023 Oct; 10(10):e653-e662. PubMed ID: 37802566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Chain Variable Fragments of Broadly Neutralizing Antibodies Prevent HIV Cell-Cell Transmission.
    van Dorsten RT; Reh L; Trkola A; Morris L; Moore PL
    J Virol; 2022 Feb; 96(4):e0193421. PubMed ID: 34935437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing antibodies for HIV-1 prevention.
    Julg B; Barouch DH
    Curr Opin HIV AIDS; 2019 Jul; 14(4):318-324. PubMed ID: 31082819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies.
    Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and Breadth.
    van Dorsten RT; Wagh K; Moore PL; Morris L
    Front Immunol; 2021; 12():734110. PubMed ID: 34603312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection.
    Awan SF; Happe M; Hofstetter AR; Gama L
    Curr Opin HIV AIDS; 2022 Jul; 17(4):247-257. PubMed ID: 35762380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs.
    Seaman MS; Bilska M; Ghantous F; Eaton A; LaBranche CC; Greene K; Gao H; Weiner JA; Ackerman ME; Garber DA; Rosenberg YJ; Sarzotti-Kelsoe M; Montefiori DC
    J Immunol Methods; 2020 Apr; 479():112736. PubMed ID: 31917969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis.
    Phelps M; Balazs AB
    Front Immunol; 2021; 12():734304. PubMed ID: 34603314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection.
    Saha A; Dixit NM
    PLoS Comput Biol; 2020 Nov; 16(11):e1008434. PubMed ID: 33253162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.